The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5453-5465

  Pritchard, D Mark ^a,b   Potten, Christopher S ^c   Hickman, John A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROTOXIN; FLUOROURACIL; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; FEMALE; GENE LOCUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL DIVISION; COLON; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA; EPITHELIUM; FEMALE; FLUOROURACIL; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MITOSIS; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032404145     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
2. Brunet, C. L., Gunby, R. H., Benson, R. S. P., Hickman, J. A., Watson, A. J. M., and Brady, G. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ., 5: 107-115, 1998.
3. McCarthy, N. J. M., Whyte, K. B., Gilbert, C. S., and Evan, G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol., 136: 215-227, 1997.
4. Xiang, J., Chao, D. T., and Korsmeyer, S. J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93: 14559-14563, 1996.
5. Lamb, J. R., and Friend, S. H. Which guesstimate is the best guesstimate? Predicting chemotherapeutic outcomes. Nat. Med., 3: 962-963, 1997.
6. Reed, J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
7. Walker, A., Taylor, S. T., Hickman, J. A., and Dive, C. Germinal center-derived signals act with bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Cancer Res., 57: 1939-1945, 1997.
8. Yin, D. X., and Schimke, R. T. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res., 55: 4922-4928, 1995.
9. Aldridge, D. R., Arends, M. J., and Radford, I. R. Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response. Br. J. Cancer, 71: 571-577, 1995.
10. Slichenmyer, W. J., Nelson, W. G., Slebos, R. J., and Kastan, M. B. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53: 4164-4168, 1993.
11. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, D. G., Bird, C. C., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
12. Lowe, S. W., Schmitt, E. S., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
13. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., and Williams, J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1035, 1997.
14. Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res., 57: 4703-4706, 1997.
15. Potten, C. S. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metast. Rev., 11: 179-195, 1992.
16. Pritchard, D. M., Watson, A. J. M., Potten, C. S., Jackman, A. L., and Hickman, J. A. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc. Natl. Acad. Sci. USA, 94: 1795-1799, 1997.
17. Floch, M. H., and Hellman, L. The effect of 5-fluorouracil on rectal mucosa. Gastroenterology, 48: 430-437, 1965.
18. Harrison, S. D., Jr., Denine, E. P., and Peckam, J. C. Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF1 mice. Cancer Treat. Rep., 62: 533-545, 1978.
19. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
20. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8: 2540-2551, 1994.
21. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
22. Merritt, A. J., Jones, L. S., and Potten, C. S. Apoptosis in murine intestinal crypts. In: T. G. Cotter and S. J. Martin (eds.), Techniques in Apoptosis, pp. 269-300. London: Portland Press Ltd., 1996.
23. Potten, C. S. A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int. J. Radiat. Biol., 58: 925-973, 1990.
24. Ijiri, K., and Potten, C. S. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br. J. Cancer, 47: 175-185, 1983.
25. Ijiri, K., and Potten. C. S. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br. J. Cancer, 55: 113-123, 1987.
26. Wright. N. A., Cart, J., and Irwin, M. The measurement of villus cell population size in the mouse small intestine in normal and abnormal states: a comparison of absolute measurements with morphometric estimators in sectioned immersion-fixed material. Cell Tissue Kinet., 22: 425-450, 1989.
27. Potten, C. S., and Hendry, J. H. The micro-colony assay in mouse small intestine. In: C. S. Potten and J. H. Hendry (eds.), Cell Clones, pp. 50-60. Edinburgh: Churchill-Livingstone, 1985.
28. Withers, H. R., and Elkind, M. M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. Radiat. Biol., 17: 261-268, 1970.
29. Wilson, J. W., and Potten, C. S. Immunohistochemical localization of BAX and BAD in the normal and BCL-2 null gastrointestinal tract. Apoptosis, 1: 183-190, 1996.
30. WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J. Pathol., 179: 248-253, 1996.
31. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
32. WAF1/CIP1 expression in the murine intestinal epithelium: apoptosis and cell cycle arrest. Am. J. Pathol., 153: 899-909, 1998.
33. Merritt, A. J., Allen, T. D., Potten, C. S., and Hickman, J. A. Apoptosis in small intestinal epithelia from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation. Oncogene, 14: 2759-2766, 1997.
34. Potten, C. S. Cell cycles in cell hierarchies. Int. J. Radiat. Biol., 49: 257-278, 1986.
35. Potten, C. S. What is an apoptotic index measuring? A commentary. Br. J. Cancer, 74: 1743-1748, 1996.
36. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8439-8497, 1995.
37. 2/M-phase transition. Mol. Cell. Biol., 18: 546-557, 1998.
38. Merritt, A. J., Potten, C. S., Kemp, C. J., Hickman, J. A., Balmain, A., Lane, D. P., and Hall, P. A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res., 54: 614-617, 1994.
39. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol., 18: 629-643, 1998.
40. Polyak, K., Waldman, T., He, T-C., Kinzler, K. W., and Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10: 1945-1952, 1996.
41. Chen, X., Ko, L. J., Jayaraman, L., and Prives, C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev., 10: 2438-2451, 1996.
42. Ronen, D., Schwartz, D., Teitz, Y., Goldfinger, N., and Rotter, V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ., 7: 21-30, 1996.
43. Lassus, P., Ferlin, M., Piette, J., and Hibner, U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J., 15: 4566-4573, 1996.
44. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
45. 1 checkpoint control. Cell, 82: 675-684, 1995.
46. Canman, C. E., Gilmer, T. M., Coutts, S. B., and Kastan, M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9: 600-611, 1995.
47. Chresta, C. M., Masters, J. R. W., and Hickman, J. A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res., 56: 1834-1841, 1996.
48. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80: 293-299, 1995.
49. Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., and Korsmeyer, S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Washington DC), 270: 96-99, 1995.
50. Heppner, G. H. Cancer cell societies and tumor progression. Stem Cells, 11: 199-203, 1993.
51. Gottlieb, E., Haffner, R., King, A., Asher, G., Gruss, P., Lonai, P., and Oren, M. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryo-genesis. EMBO J., 16: 1381-1390, 1997.
52. Komarova, E. A., Chernov, M. V., Franks, R., Wang, K., Armin, G., Zelnick, C. R., Chin, D. M., Bacus, S. S., Stark, G. R., and Gudkov, A. V. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J., 16: 1391-1400, 1997.
53. MacCallum, D. E., Hupp, T. R., Midgley, C. A., Stuart, D., Campbell, S. J., Harper, A., Walsh, F. S., Wright, E. G., Balmain, A., Lane, D. P., and Hall, P. A. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene, 13: 2575-2587, 1996.
54. Hickman, J. A., and Boyle, C. C. Apoptosis and cytotoxins. Br. Med. Bull., 52: 632-643, 1997.